BG64596B1 - Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази - Google Patents

Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази Download PDF

Info

Publication number
BG64596B1
BG64596B1 BG102661A BG10266198A BG64596B1 BG 64596 B1 BG64596 B1 BG 64596B1 BG 102661 A BG102661 A BG 102661A BG 10266198 A BG10266198 A BG 10266198A BG 64596 B1 BG64596 B1 BG 64596B1
Authority
BG
Bulgaria
Prior art keywords
alkyl
benzo
group
phenyl
quinolizin
Prior art date
Application number
BG102661A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102661A (en
Inventor
Antonio Guarna
Mario Serio
Original Assignee
Applied Research Systems Ars Holding N.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems Ars Holding N.V. filed Critical Applied Research Systems Ars Holding N.V.
Publication of BG102661A publication Critical patent/BG102661A/xx
Publication of BG64596B1 publication Critical patent/BG64596B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
    • C07D455/06—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine containing benzo [a] quinolizine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/28—Antiandrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BG102661A 1996-02-09 1998-07-30 Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази BG64596B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96FI000019A IT1286545B1 (it) 1996-02-09 1996-02-09 Derivati benzo(c) chinolizinici,loro preparazione ed uso come inibitori delle 5-alfa-riduttasi

Publications (2)

Publication Number Publication Date
BG102661A BG102661A (en) 1999-04-30
BG64596B1 true BG64596B1 (bg) 2005-08-31

Family

ID=11351478

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102661A BG64596B1 (bg) 1996-02-09 1998-07-30 Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази

Country Status (26)

Country Link
US (3) US6303622B1 (xx)
EP (1) EP0880520B1 (xx)
JP (1) JP2000504680A (xx)
KR (1) KR100480448B1 (xx)
CN (1) CN1116296C (xx)
AT (1) ATE237614T1 (xx)
AU (1) AU711886C (xx)
BG (1) BG64596B1 (xx)
CZ (1) CZ298061B6 (xx)
DE (1) DE69720966T2 (xx)
DK (1) DK0880520T3 (xx)
EA (1) EA000975B1 (xx)
EE (1) EE04058B1 (xx)
ES (1) ES2192263T3 (xx)
HK (1) HK1018783A1 (xx)
HU (1) HUP9900509A3 (xx)
IL (2) IL125628A0 (xx)
IT (1) IT1286545B1 (xx)
MX (1) MX9806229A (xx)
NO (2) NO320155B1 (xx)
NZ (1) NZ331256A (xx)
PL (1) PL187618B1 (xx)
PT (1) PT880520E (xx)
SK (1) SK283299B6 (xx)
UA (1) UA67724C2 (xx)
WO (1) WO1997029107A1 (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI970193A1 (it) * 1997-08-01 1999-02-01 Applied Research Systems Uso di derivati benzo(c) chinolizinici come regolatori della crescita delle piante e composizioni ad uso agricolo che contengono tali
EP0926148A1 (en) * 1997-12-23 1999-06-30 Applied Research Systems Ars Holding N.V. Benzo (C)quinolizine derivatives, their preparation and use as 5-alphareductases inhibitors
KR100624239B1 (ko) * 1998-08-03 2006-09-13 어플라이드 리서치 시스템스 에이알에스 홀딩 엔.브이. (1ｈ)-벤조〔ｃ〕퀴놀리진-3-온 유도체의 합성방법
EA015252B1 (ru) 2005-05-10 2011-06-30 Интермьюн, Инк. Способ модуляции стресс-активированной протеинкиназной системы
US20070155738A1 (en) * 2005-05-20 2007-07-05 Alantos Pharmaceuticals, Inc. Heterobicyclic metalloprotease inhibitors
AU2006251989B2 (en) * 2005-05-20 2010-05-27 Alantos-Pharmaceuticals, Inc. Pyrimidine or triazine fused bicyclic metalloprotease inhibitors
CN102099036B (zh) 2008-06-03 2015-05-27 英特芒尼公司 用于治疗炎性疾患和纤维化疾患的化合物和方法
AR092742A1 (es) 2012-10-02 2015-04-29 Intermune Inc Piridinonas antifibroticas
CN110452216B (zh) 2014-04-02 2022-08-26 英特穆恩公司 抗纤维化吡啶酮类
CN105001216B (zh) * 2015-07-08 2017-03-01 中国科学院兰州化学物理研究所 一种喹嗪酮的制备方法
CN107089980B (zh) * 2017-05-11 2019-08-30 合肥工业大学 一种手性苯并[a]喹嗪-2-酮类化合物及其不对称催化合成方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455929A (en) * 1966-08-15 1969-07-15 Bristol Myers Co Esters of 1,4-dihydroquinoline-n-carboxylic acids and thione acids
FR1534278A (fr) * 1966-08-15 1968-07-26 Bristol Myers Co Procédé de fabrication de 1, 4-dihydroquinoléine-n-carboxylates d'alcoyle
US3625877A (en) * 1968-01-08 1971-12-07 Eastman Kodak Co High-modulus polycarbonate compositions
SU1027166A1 (ru) * 1981-09-11 1983-07-07 Киевский Ордена Ленина Государственный Университет Им.Т.Г.Шевченко Способ получени 1,2-полиметиленкетоцианоазагетероциклов
IE57014B1 (en) 1983-03-25 1992-03-11 Wyeth John & Brother Ltd Benzoquinolizines

Also Published As

Publication number Publication date
DE69720966T2 (de) 2004-05-19
NO20045132L (no) 1998-07-24
IL125628A0 (en) 1999-04-11
EE04058B1 (et) 2003-06-16
UA67724C2 (en) 2004-07-15
IT1286545B1 (it) 1998-07-15
NZ331256A (en) 1999-06-29
MX9806229A (es) 1998-11-30
US6552034B2 (en) 2003-04-22
JP2000504680A (ja) 2000-04-18
KR100480448B1 (ko) 2005-08-31
AU711886B2 (en) 1999-10-21
NO983444D0 (no) 1998-07-24
IL125628A (en) 2006-10-31
KR19990082126A (ko) 1999-11-15
ES2192263T3 (es) 2003-10-01
EP0880520A1 (en) 1998-12-02
EP0880520B1 (en) 2003-04-16
CN1210536A (zh) 1999-03-10
BG102661A (en) 1999-04-30
EA199800701A1 (ru) 1999-02-25
DK0880520T3 (da) 2003-08-11
AU711886C (en) 2002-10-17
US20010044542A1 (en) 2001-11-22
US20010047098A1 (en) 2001-11-29
NO983444L (no) 1998-07-24
AU1767297A (en) 1997-08-28
NO320155B1 (no) 2005-11-07
HUP9900509A2 (hu) 1999-06-28
ITFI960019A0 (xx) 1996-02-09
CN1116296C (zh) 2003-07-30
HUP9900509A3 (en) 1999-11-29
US6303622B1 (en) 2001-10-16
EA000975B1 (ru) 2000-08-28
HK1018783A1 (en) 2000-01-07
CZ228998A3 (cs) 1998-10-14
DE69720966D1 (de) 2003-05-22
SK104498A3 (en) 1998-12-02
EE9800233A (et) 1998-12-15
ITFI960019A1 (it) 1997-08-09
US6555549B2 (en) 2003-04-29
CZ298061B6 (cs) 2007-06-06
WO1997029107A1 (en) 1997-08-14
PL328123A1 (en) 1999-01-18
PT880520E (pt) 2003-07-31
ATE237614T1 (de) 2003-05-15
PL187618B1 (pl) 2004-08-31
SK283299B6 (sk) 2003-05-02

Similar Documents

Publication Publication Date Title
EP0995743B1 (fr) Dérivés de dihydro- et tétrahydroquinoléine en tant qu'antioxydant médical
EA002146B1 (ru) Производные амида гетероарил-гексановой кислоты, их получение и их применение в качестве селективных ингибиторов связывания mip-1-альфа с его рецептором ccr1
BG64596B1 (bg) Бензо[с]хинолизинови производни, тяхното получаване и използване като инхибитори на 5 алфа-редуктази
CH644607A5 (fr) Octahydro-pyrazolo(3,4-g)quinoleines.
US5910498A (en) Pyridonecarboxylic acid derivatives or salts thereof and antibacterial agents comprising the same as active ingredient
JP3014146B2 (ja) ビス−インドリルマレイミド類の合成
KR19990064356A (ko) 류코트리엔 생합성 억제제로서의 대칭성 비스-헤테로아릴메톡시페닐알킬 카복실레이트
Kunitomo et al. Structure and synthesis of menisporphine, a new type of isoquinoline alkaloid: alkaloids of Menispermum dauricum DC.(9)
CZ2001434A3 (cs) Způsob výroby chinolizin-3-onových derivátů
JP2005530691A (ja) 新規なチロインジシンとその関連プロセス、薬学的組成物および方法
JPH10512899A (ja) Ｎ−アセチルアルデエミンの類似体、それらの調製及び使用方法
EP1066284B1 (en) Benzo(c)quinolizine derivatives and their use as 5 alpha-reductases inhibitors
CA2245758C (en) Benzo[c]quinolizine derivatives, their preparation and use as 5.alpha.-reductases inhibitors
KR0153530B1 (ko) 락탐 유도체의 제조 방법
US20200140444A1 (en) Inhibitors of mutant isocitrate dehydrogenases and compositions and methods thereof
JPH02115182A (ja) 光学活性ピリドンカルボン酸化合物
FR2787452A1 (fr) Nouveaux derives de la benzonaphtyridine-1,8, leur preparation et les compositions pharmaceutiques qui les contiennent
FR2795729A1 (fr) Nouveaux derives de la benzo[f]naphtyridine, leur preparation et les compositions les contenant